InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Protopapas Anna, Chairman & CEO. Officer active across 2 companies, notably Dicerna Pharmaceuticals Inc. In total, 6 filings have been logged. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations6 total
38,958 shares
Common Stock
SEC:0001104659-22-005548·
38,958 shares
Common Stock
SEC:0001104659-22-005548:0·
100,000 shares
Common Stock
SEC:0001104659-21-093665·
100,000 shares
Common Stock
SEC:0001104659-21-093665:0·
3,333 shares
Common Stock
SEC:0001399529-21-000107·
3,333 shares
Common Stock
SEC:0001399529-21-000107:0·
6 of 6 declarations
About Protopapas Anna
Anna Protopapas serves as President & CEO of Dicerna Pharmaceuticals Inc and Mersana Therapeutics, Inc. She leads the operations of both companies, ensuring that development strategies align with market needs. Her experience in the biopharmaceutical sector is an asset for the growth of these companies.
